VCEL Live signaler | Maksimer profitt med Getagraph.com

SELG 111329 min ago

@ $47.14

Utstedt: 14 feb 2024 @ 18:51

Avkastning: -0.13%

Forrige signal: feb 13 - 15:30

Forrige signal: Kjøp

Avkastning: 5.65 %

Live Chart Being Loaded With Signals

Commentary (1 mai 2024 @ 22:00):

Stats
Dagens volum	454 722
Gjennomsnittsvolum	428 539
Markedsverdi	2.28B
EPS	$0 ( 2024-02-29 )
Neste inntjeningsdato	( $-0.110 ) 2024-05-08
Last Dividend	$0 ( N/A )
Next Dividend	$0 ( N/A )
P/E	-672.57
ATR14	$0.108 (0.23%)

Insider Trading

Date	Person	Action	Amount	type
2024-04-30	Colangelo Dominick	Buy	6 002	Stock Option (Right to Buy)
2024-04-30	Colangelo Dominick	Buy	13 888	Stock Option (Right to Buy)
2024-04-30	Colangelo Dominick	Buy	5 555	Common Stock
2024-04-30	Colangelo Dominick	Buy	5 555	Stock Option (Right to Buy)
2024-04-30	Colangelo Dominick	Buy	6 002	Common Stock

INSIDER POWER
68.00
Last 100 transactions
Buy: 883 338 \| Sell: 166 323

Volum Korrelasjon

Lang: -0.07 (neutral)

Kort: -0.56 (weak negative)

Signal:(25.467) Neutral

Vericel Corp Korrelasjon

10 Mest positive korrelasjoner
CSLMU	0.902
CLBT	0.89
ATCX	0.885
BRACU	0.885
CRVL	0.875
CMPO	0.872
ARAY	0.871
CVT	0.866
BYNOU	0.865
EYEN	0.865

10 Mest negative korrelasjoner
NAKD	-0.887
TRIT	-0.884
PRPH	-0.88
VIEW	-0.871
RAVN	-0.868
LAWS	-0.86
CHKEL	-0.859
SYBT	-0.856
PROC	-0.855
HTBK	-0.855

Visste du det?

Korrelasjon er en statistisk måling som beskriver forholdet mellom to variabler. Den varierer fra -1 til 1, hvor -1 indikerer en perfekt negativ korrelasjon (hvor en variabel øker, går den andre ned), 1 indikerer en perfekt positiv korrelasjon (hvor en variabel øker, går den andre også opp), og 0 indikerer ingen korrelasjon (det er ingen forhold mellom variablene).

Korrelasjon kan brukes til å analysere forholdet mellom to variabler, ikke bare aksjer. Det er vanligvis brukt innen områder som finans, økonomi, psykologi, og mer.

Vericel Corp Korrelasjon - Valuta/Råvare

-0.69
( moderate negative )

-0.84
( strong negative )

-0.65
( weak negative )

0.03
( neutral )

0.66
( moderate )

Vericel Corp Økonomi

Annual	2023
Omsetning:	$197.52M
Bruttogevinst:	$135.58M (68.64 %)
EPS:	$-0.0669

FY	2023
Omsetning:	$197.52M
Bruttogevinst:	$135.58M (68.64 %)
EPS:	$-0.0669

FY	2022
Omsetning:	$164.37M
Bruttogevinst:	$109.79M (66.80 %)
EPS:	$-0.350

FY	2021
Omsetning:	$156.18M
Bruttogevinst:	$106.03M (67.88 %)
EPS:	$-0.160

Financial Reports:

No articles found.

Vericel Corp

Vericel Corporation, a commercial-stage biopharmaceutical company, engages in the research, development, manufacture, and distribution of cellular therapies for sports medicine and severe burn care markets in the United States. The company markets autologous cell therapy products comprising MACI, an autologous cellularized scaffold product for the repair of symptomatic, and single or multiple full-thickness cartilage defects of the knee; and Epicel, a permanent skin replacement humanitarian use device for the treatment of adult and pediatric patients with deep-dermal or full-thickness burns. Its preapproval stage product is NexoBrid, a registration-stage biological orphan product for eschar removal in adults with deep partial-thickness and/or full-thickness thermal burns. The company was formerly known as Aastrom Biosciences, Inc. Vericel Corporation was incorporated in 1989 and is headquartered in Cambridge, Massachusetts.